Entrada Therapeutics Inc. (TRDA)
NASDAQ: TRDA
· Real-Time Price · USD
5.29
0.04 (0.76%)
At close: Aug 15, 2025, 3:59 PM
5.27
-0.28%
After-hours: Aug 15, 2025, 04:10 PM EDT
Entrada Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 72.48M | 67.84M | 101.21M | 78.05M | 185.25M | 68.44M | 67.6M | 51.88M | 376.79M | 227.65M | 45.16M | 53.31M | 90.87M | 84.64M | 291.06M | 122.17M | 136.95M | n/a |
Short-Term Investments | 281.53M | 314.68M | 318.79M | 371.3M | 284.49M | 258.98M | 284.37M | 301.7M | 297.05M | 183.98M | 143.56M | 162.26M | 153.39M | 179.26M | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | 3.95M | 3.95M | 3.95M | 3.95M | 3.95M | 3.95M | 3.95M | 3.95M | 3.95M | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 4.15M | 4.19M | 4.23M | 4.7M | 747K | 2.76M | 2.79M | 2.98M | 538K | 13.84M | 5.21M | 954K | 875K | 5.38M | 872K | 2.97M | 791K | -39.05M |
Receivables | n/a | 2.04M | 3.68M | 2.6M | n/a | 77.51M | n/a | 5.03M | 3.74M | 6.3M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.03M | n/a | 183.98M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 15.13M | 18.63M | 16.36M | 13.39M | 19.79M | 9.24M | 17.8M | 1.6M | 9.66M | 16.21M | 21.16M | 19.16M | 9.65M | 8.81M | n/a | 1.35M | n/a | n/a |
Total Current Assets | 369.15M | 403.19M | 440.04M | 465.33M | 489.54M | 414.17M | 369.77M | 383.04M | 390.19M | 434.13M | 209.88M | 234.73M | 253.9M | 272.71M | 298.7M | 123.53M | 137.64M | 39.05M |
Property-Plant & Equipment | 75.49M | 79.1M | 82.05M | 84.56M | 87.73M | 89.96M | 92.68M | 95.06M | 99.3M | 23.64M | 33.02M | 34.83M | 37.19M | 38.61M | 6.26M | 5.9M | 5.09M | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 79.64M | 83.29M | 86.28M | 89.25M | 92.43M | 96.67M | 99.42M | 101.99M | 103.79M | 41.43M | 42.18M | 39.73M | 42.01M | 43.99M | 7.13M | 8.87M | 5.88M | -39.05M |
Total Assets | 448.78M | 486.48M | 526.32M | 554.59M | 581.96M | 510.84M | 469.19M | 485.03M | 493.98M | 475.57M | 252.06M | 274.46M | 295.92M | 316.7M | 305.83M | 132.4M | 143.51M | n/a |
Account Payables | 1.86M | 2.19M | 4.26M | 1.29M | 1.64M | 2.53M | 3.28M | 752K | 2.42M | 6.47M | 5.99M | 1.34M | 4.62M | 2.93M | 706K | 2.28M | 1.88M | n/a |
Deferred Revenue | 689K | 1.35M | 13.65M | 45.92M | 60.5M | 148.46M | 132.26M | 148.44M | 101.64M | 122.34M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 5.46M | n/a | n/a | n/a | 8.57M | n/a | 7.91M | 6.64M | 7.41M | 7.1M | n/a | 8.26M | 8.11M | 7.97M | n/a | n/a | n/a | n/a |
Other Current Liabilities | 11.79M | 4.24M | 8.43M | -182K | 2.96M | 5.75M | 3.78M | -564K | 4.31M | -1.03M | 431K | -341K | -5.13M | -5.08M | 485K | 823K | 413K | n/a |
Total Current Liabilities | 19.8M | 18.43M | 39.48M | 70.6M | 85.81M | 173.94M | 158.8M | 165.43M | 125.94M | 147.59M | 21.97M | 21.55M | 18.08M | 15.43M | 6.72M | 7.16M | 4.54M | n/a |
Long-Term Debt | 49.28M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 194K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 396K | 197.83M | 197.99M | -40.17M |
Total Long-Term Liabilities | 49.48M | 50.79M | 58.16M | 61.54M | 66.23M | 67.54M | 68.04M | 72.94M | 161.13M | 98.36M | 17.53M | 19.69M | 21.8M | 23.89M | 396K | 197.83M | 197.99M | -40.17M |
Total Liabilities | 69.28M | 69.22M | 97.64M | 132.14M | 152.04M | 241.48M | 226.83M | 238.37M | 287.07M | 245.96M | 39.5M | 41.24M | 39.88M | 39.31M | 7.12M | 204.99M | 202.53M | -40.17M |
Total Debt | 54.74M | 57M | 59.21M | 61.31M | 64.44M | 66.43M | 68.23M | 69.07M | 73.03M | 16.23M | 25.94M | 27.95M | 29.91M | 31.86M | n/a | n/a | n/a | n/a |
Common Stock | 4K | 4K | 4K | 4K | 4K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | n/a | n/a | n/a |
Retained Earnings | -189.8M | -146.69M | -129.34M | -130.47M | -116.44M | -171.47M | -194.97M | -185.43M | -220.89M | -194.96M | -188.28M | -163.66M | -138.52M | -115.34M | -93.67M | -75.22M | -60.79M | n/a |
Comprehensive Income | 400K | 437K | -43K | 972K | -329K | -246K | 195K | -496K | -1M | -642K | -2.06M | -2.75M | -2.27M | -1.53M | n/a | n/a | n/a | -41.49M |
Shareholders Equity | 379.5M | 417.26M | 428.68M | 422.45M | 429.93M | 269.37M | 242.36M | 246.66M | 206.91M | 229.61M | 212.55M | 233.22M | 256.04M | 277.39M | 298.72M | -72.59M | -59.01M | 40.17M |
Total Investments | n/a | 314.68M | 318.79M | 371.3M | 288.44M | 262.93M | 288.32M | 301.7M | 297.05M | 183.98M | 143.56M | 162.26M | 153.39M | 179.26M | n/a | n/a | n/a | n/a |